Companies Dominating the AI-based Clinical Trials Solution Providers Landscape
- Unlearn.AI, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Saama Technologies, LLC.
- Antidote Technologies, Inc.
- Biosymetrics
- Pharmaceutical Pipeline Enhancement Strategies, LLC
- Deep 6 AI Inc.
- Innoplexus AG
- Mendel.ai
- Intelligencia
- Median Technologies
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
AI-based Clinical Trials Solution Providers Market in 2025 is evaluated at USD 1.73 billion.
The global market size was worth around USD 1.47 billion in 2024 and is set to register a CAGR of more than 21.8%, exceeding USD 19.09 billion revenue by 2037.
North America is likely to surpass largest share by 2037, attributed to increasing penetration of AI-based tools and rising government initiatives.
The major players in the market include Unlearn.AI, Inc., Saama Technologies, LLC., Antidote Technologies, Inc., Biosymetrics, Pharmaceutical Pipeline Enhancement Strategies, LLC, Deep 6 AI Inc., Innoplexus AG, Mendel.ai, Intelligencia, Median Technologies.
